Learn About GLP-1 Medications and How They Work

What Are GLP-1 Medications and Where Did They Come From

GLP-1 medications are a class of drugs that work by mimicking a natural hormone your body produces called glucagon-like peptide-1. This hormone plays an important role in regulating blood sugar levels and appetite. The first GLP-1 medication was developed in the late 1990s, based on research into how certain hormones in the body help control diabetes. Scientists discovered that by creating medications that act like this natural hormone, they could help people manage type 2 diabetes more effectively.

The name "GLP-1" comes from the full name of the hormone: glucagon-like peptide-1. When you eat food, your body naturally releases this hormone from cells in your intestines. The hormone then tells your pancreas to release insulin when blood sugar rises, helping to bring those levels back down to normal. It also signals your brain that you feel full, which helps control how much you eat. Medications in this class work by doing similar things, but they stay active in your body longer than the natural hormone does.

In recent years, GLP-1 medications have gained significant attention. According to the CDC, type 2 diabetes affects more than 37 million people in the United States, and about 90-95% of people with diabetes have type 2. This widespread condition created demand for new treatment options. Additionally, researchers noticed that people taking these medications for diabetes often lost weight, which opened up new uses for these drugs.

The most well-known GLP-1 medications include semaglutide (sold under brand names like Ozempic and Wegovy), tirzepatide (Zepbound and Mounjaro), dulaglutide (Trulicity), and liraglutide (Saxenda and Victoza). Each medication has slightly different chemical structures, approval timelines, and uses. Some are primarily used for diabetes, while others focus on weight management, though many can be prescribed for either purpose depending on individual circumstances.

Practical Takeaway: Understanding that GLP-1 medications mimic a natural body process can help you grasp why they work the way they do. These aren't new chemical inventions but rather lab-created versions of something your body already makes. This foundation helps explain how they affect blood sugar and appetite in the sections that follow.

How GLP-1 Medications Work in Your Body

GLP-1 medications function through several interconnected processes in your body. When you take these medications, they activate GLP-1 receptors—special attachment points found throughout your body. These receptors are particularly concentrated in three key areas: your pancreas, your stomach and digestive system, and your brain. By activating these receptors, GLP-1 medications trigger a chain of biological responses that affect how your body handles food and blood sugar.

In the pancreas, GLP-1 medications stimulate beta cells to release insulin, but only when blood sugar is elevated. This is an important distinction from some other diabetes medications, which cause insulin release regardless of blood sugar levels. This targeted approach means the medication helps lower blood sugar when needed while reducing the risk of your blood sugar dropping dangerously low (a condition called hypoglycemia). When blood sugar is already normal, the medication doesn't trigger extra insulin release, which is a safety advantage.

GLP-1 medications also slow down how quickly food moves through your stomach and small intestine—a process called gastric emptying. When food moves more slowly through your digestive system, it takes longer for glucose (sugar) from that food to enter your bloodstream. This slower entry means blood sugar rises more gradually and stays more stable throughout the day. This effect explains why people taking these medications often feel full longer after eating and experience fewer blood sugar spikes after meals.

At the brain level, GLP-1 medications interact with appetite control centers, particularly in an area called the hypothalamus. These medications increase satiety signals, which means they make your brain perceive that you're fuller than you might actually be. They also appear to reduce cravings and change how much pleasure your brain gets from eating. Research published in medical journals shows that these appetite-suppressing effects are substantial—many people report significantly less desire to eat within days of starting the medication.

Additionally, GLP-1 medications may have effects on your liver. Your liver controls how much glucose it produces and releases into your bloodstream. GLP-1 medications help reduce excessive glucose production by the liver, which is particularly important because people with type 2 diabetes often produce too much glucose, even when they haven't eaten. This action helps keep fasting blood sugar levels (blood sugar measured after you haven't eaten for several hours) within a healthier range.

Practical Takeaway: GLP-1 medications work through multiple pathways—insulin release, slower digestion, appetite suppression, and liver function. Because they work on several systems simultaneously, they tend to be quite effective, but understanding these different mechanisms also helps explain why different people may experience different side effects or different levels of benefit.

Medical Uses and FDA Approvals for GLP-1 Medications

GLP-1 medications have received approval from the Food and Drug Administration (FDA) for specific medical purposes. The primary original use was type 2 diabetes management. In this disease, the body either doesn't produce enough insulin or can't use insulin effectively (a condition called insulin resistance). By helping the pancreas release insulin when needed and making cells more responsive to insulin, GLP-1 medications help people with type 2 diabetes maintain healthier blood sugar levels. The American Diabetes Association recognizes GLP-1 receptor agonists as an important class of medications for diabetes treatment.

The FDA also approved certain GLP-1 medications specifically for weight management. Semaglutide received FDA approval under the brand name Wegovy for chronic weight management in adults with obesity or who are overweight with weight-related conditions. Tirzepatide received approval under the brand name Zepbound for chronic weight management. These approvals came because clinical trials showed significant weight loss results. In trials, people taking semaglutide for weight management lost an average of 15% of their body weight over 68 weeks, according to FDA approval documents. Tirzepatide showed even larger weight loss in trials—some patients lost 20% or more of their body weight.

Beyond FDA-approved uses, doctors sometimes prescribe medications for off-label purposes, meaning uses not specifically approved by the FDA but supported by medical evidence. This practice is legal and common in medicine. For example, a doctor might prescribe a GLP-1 medication approved for diabetes to a person without diabetes who has obesity, based on the medication's effects on appetite and weight. However, off-label use means the doctor is making an individual clinical decision rather than following an FDA-approved indication.

Some GLP-1 medications also have approval for cardiovascular benefits. Studies have shown that certain GLP-1 medications reduce the risk of heart attack and stroke in people with type 2 diabetes, particularly those with existing heart disease. This means some doctors may prescribe these medications not just for blood sugar or weight control but specifically to protect heart health. Semaglutide, for instance, showed in clinical trials that it reduced major cardiovascular events by 26% compared to a placebo in people with type 2 diabetes and heart disease.

Different GLP-1 medications have different approval timelines and indications. Some are longer-acting (you take them once per week), while others require more frequent dosing. Some are tablets, while others are injections. Your doctor would choose a specific medication based on your individual health needs, other conditions you have, and practical factors like whether you prefer injections or pills.

Practical Takeaway: GLP-1 medications are FDA-approved for specific uses—primarily type 2 diabetes and weight management—though doctors may use them for other purposes based on clinical judgment. Understanding the difference between FDA-approved uses and off-label uses helps you have informed conversations with healthcare providers about why a particular medication might be recommended for you.

Common Side Effects and How They Typically Develop

GLP-1 medications do cause side effects in many people, though not everyone experiences them equally. The most common side effects relate to the digestive system and are connected directly to how these medications work. Nausea is the most frequently reported side effect, occurring in 20-40% of people taking these medications, depending on the specific drug and dose. The nausea typically occurs because the medication slows gastric emptying (how fast food moves